Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05891548
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-02
First Post:
2023-05-24
Brief Title:
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
Sponsor:
Clearside Biomedical Inc
Organization:
Clearside Biomedical Inc
Organization Data
Organization:
Clearside Biomedical Inc
Class:
INDUSTRY
Study ID:
CLS1002-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Clearside Biomedical Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None